蛋白质晶片全球市场规模、份额、成长分析（按技术、按应用、按最终用户）- 2024-2031 年产业预测

预计2022年全球蛋白质晶片市场规模为7.1306亿美元，从2023年的7.6654亿美元增长到2031年的13.6711亿美元，并预计在预测期内（2024-2031年）继续增长。2019 年复合年增长率为7.5%。

蛋白质体学研究、个人化医疗和药物开发正在推动全球蛋白质晶片市场的变革时期。由于人们越来越关注了解蛋白质相互作用及其在疾病中的重要性，对蛋白质晶片的需求正在迅速增加。这些微阵列能够进行高通量蛋白质分析，使科学家能够同时检查许多蛋白质。该市场是老字型大小企业和创意企业家的混合体，竞争非常激烈。产品开发是由技术进步所驱动的。蛋白质晶片的应用遍及各个领域，包括生物技术、临床诊断、製药和大学研究。总体而言，全球蛋白质晶片市场正在迅速扩大，因为科学家仍在了解蛋白质的复杂性及其与许多领域的关係。区域市场的变化、应用的成长和技术创新预计都会影响未来几年市场的方向。

目录

执行摘要

• 市场概况
• 命运之轮

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管形势
• 波特的分析
• 对未来中断的特殊考虑

全球蛋白质晶片市场：依技术分类

• 市场概况
• 分析微阵列
• 功能蛋白微阵列
• 反相蛋白质微阵列

全球蛋白质晶片市场：依应用分类

• 市场概况
• 诊断
• 蛋白质体学
• 抗体表征

全球蛋白质晶片市场：依最终用户分类

• 市场概况
• 医院/诊所
• 诊断实验室
• 学术研究所
• 製药和生物技术公司

全球蛋白质晶片市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争形势

• 前5名企业对比
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• Agilent Technologies（US）
• PerkinElmer（US）
• Bio-Rad Laboratories（US）
• Thermo Fisher Scientific（US）
• Sigma-Aldrich Corporation（US）
• Illumina（US）
• GE Healthcare（US）
• Bruker Corporation（US）
• Shimadzu Corporation（Japan）
• Roche Diagnostics（Switzerland）
• RayBiotech（US）
• Gyros Protein Technologies（UK）
• Innopsys（France）
• Randox Laboratories（UK）
• HORIBA, Ltd.（Japan）
• CapitalBio Corporation（China）
• Biotech Support Group（US）
• Surmodics（US）
• PerkinElmer（US）
• Innova Biosciences（UK）

Global Protein Chip Market size was valued at USD 713.06 million in 2022 and is poised to grow from USD 766.54 million in 2023 to USD 1367.11 million by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

Proteomic research, personalized medicine, and drug development are driving a transformative era in the Global Protein Chip Market. The market is seeing a spike in demand for protein chips due to an increasing focus on comprehending protein interactions and their significance in illnesses. These microarrays make high-throughput protein analysis possible, allowing scientists to examine many proteins at once. There is fierce rivalry as a result of the market's mix of well-established firms and creative entrepreneurs. Product development is being encouraged by technological advancements. Applications for protein chips can be found in many fields, such as biotechnology, clinical diagnostics, medicines, and university research. Since scientists are still learning about the intricacies of proteins and how they relate to many fields, the global market for protein chips is expanding rapidly overall. In the upcoming years, it is expected that regional market changes, growing applications, and technological innovation will all influence the market's direction.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein Chip Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Protein Chip Market Segmental Analysis

The segmentation of the Global Protein Chip Market is based on end user, geography, technology, and application. It is separated into three categories based on technology: reverse phase protein microarrays, functional protein microarrays, and analytical microarrays. Proteomics, antibody characterisation, and diagnostics are included in the application segment. Hospitals and clinics, diagnostic labs, educational and research facilities, and pharmaceutical and biotechnological businesses are all included in the end user segment. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.

Drivers of the Global Protein Chip Market

There has been a noticeable change in lifestyle in the modern world, which has increased the incidence of cancer. This tendency has been influenced by elements including increased drug and alcohol misuse, tobacco usage, and alcohol intake. In addition, the prevailing sedentary lifestyle has led to a decrease in physical activity, which in turn has resulted in obesity-the main cause of many chronic lifestyle-related illnesses. The population's diabetes has been exacerbated by this sedentary lifestyle and the consumption of highly processed, sugary, and nutritionally lacking items from the many fast-food franchises. In addition, environmental factors such as air pollution have contributed to the rising cancer incidence rates.

Restraints in the Global Protein Chip Market

Since proteins are tiny and lose form and structure when removed from their native environment, they must be extracted from live creatures. This fragility makes it difficult to gather enough samples for examination, which presents problems for the market for protein chips. The main challenges are the lack of sample data and the analytical difficulties brought on by the small sample size. Because of their intrinsically microscopic character, analysis may miss significant protein expressions.

Market Trends of the Global Protein Chip Market

The need for protein chips has increased due to the trend toward customized medicine since they make it possible to analyze unique protein profiles and biomarkers. This makes it possible for medical professionals to customize care according to each patient's own molecular profile, which produces better results.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Protein Chip Market by Technology

• Market Overview
• Analytical microarrays
• functional protein microarrays
• and reverse phase protein microarrays

Global Protein Chip Market by Application

• Market Overview
• Diagnostics
• proteomics
• and antibody characterization

Global Protein Chip Market by End user

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• and Pharmaceutical & Biotechnological Companies

Global Protein Chip Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gyros Protein Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innopsys (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HORIBA, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapitalBio Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotech Support Group (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surmodics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innova Biosciences (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments